What you believe and what you value as an organization matters. Discover the DNA of our firm.
Get to know our teams and the stories of select staff members who share why they choose to work at Sands Capital.
Sands Capital is one of just four investment managers recognized this year for the service it delivers to institutional clients.
U.S. markets have recovered following 2022’s historic selloff, leading some to question what comes next. In this environment, we believe certain active approaches are better positioned to benefit than others.
Bryan Gold and #paid are enabling companies and creators to form mutually beneficial partnerships
Executive Managing Director and Sr. Portfolio Manager Brian Christiansen discusses the importance of candor and collaboration in a culture that promotes long-term thinking.
Recruit Holdings is transforming the world of work through wage transparency and providing life-changing opportunities for immigrants and refugees.
Our philosophy is rooted in the belief that, over time, stock prices will reflect the earnings power and growth of the underlying businesses.
Our second annual stewardship report reflects our commitment to provide clients and other key stakeholders with transparency into our initiatives, actions, and the progress we made in 2022.
Our newest strategy takes an unconstrained approach to seeking the best growth businesses outside of the U.S.
Our life sciences strategy looks to invest in promising life sciences companies that we believe are at the heart of a technological and scientific revolution in healthcare.
Partner
2021
RA Capital (2020 - 2021)
Boston, MA | Principal, Tools and Diagnostics
Farcast Biosciences / Mitra Biotech (2015 - 2020)
Woburn, MA | Head of Strategy, Chief Commercial Officer
RA Capital (2015)
Boston, MA | Entrepreneur in Residence
Becton Dickinson (2006 - 2014)
Franklin Lakes, NJ | VP
Serologicals / Upstate Biotechnology (2000 - 2006)
Charlottesville, VA | VP
Pratt & Whitney (1996 - 1998)
Hartford, CT | Manufacturing Engineer
University of Virginia (2000)
MBA | Darden School
Boston University (1995)
BS | Mechanical Engineering
Parker is a Partner of the Sands Capital Life Sciences Pulse Strategy and joined Sands Capital in 2021. Parker has 20 years of operational experience with life science tools, diagnostics and device companies in a range of commercial, development and general management roles. In those roles, he’s been accountable for revenue ranging from launch up to $70M annually, he’s led acquisitions and integrations and he’s designed and executed multiple clinical trials. He has been an advisor, investor and board member for private life science companies since 2015. Parker has a degree in Mechanical Engineering from Boston University and an MBA from the Darden School at the University of Virginia.
An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, Sands Capital managed more than $46 billion in client assets as of September 30, 2023.
For institutional and professional investors only. Investment advisory fees are described in Part II of the adviser’s Form ADV.